NCT03893526View on ClinicalTrials.gov

Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 25, 2019

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions
Type2 Diabetes
Interventions
DRUG

Entresto

Single dose administration of entresto

DRUG

Sitagliptin

Single dose administration of sitagliptin

DRUG

Valsartan

single doses administration of valsartan

DRUG

Placebo

placebo day

Trial Locations (1)

2650

Hvidovre Hospital, Hvidovre

All Listed Sponsors
collaborator

Hvidovre University Hospital

OTHER

lead

University of Copenhagen

OTHER

NCT03893526 - Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter